ResMed Inc (NYSE:RMD)
| 50.75 Real-Time Quote |  -0.35 / -0.68%Today’s Change | 41.52 Today|||52-Week Range 57.34 | +7.80% Year-to-Date |
Latest RMD News | Press Releases
Today’s Trading
| Previous close | 51.10 |
| Today’s open | 51.00 |
| Day’s range | 50.48 - 51.13 |
| Volume | 112,991 |
| Average volume (3 months) | 765,439 |
| Market cap | $7.2B |
| Dividend yield | 1.97% |
Data as of 10:18am ET, 07/28/2014
Growth & Valuation
| Earnings growth (last year) | +22.81% |
| Earnings growth (this year) | +8.12% |
| Earnings growth (next 5 years) | +13.50% |
| Revenue growth (last year) | +10.66% |
| P/E ratio | 22.3 |
| Price/Sales | 4.26 |
| Price/Book | 4.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | 0.00 | 0.00% |
| TFXTeleflex Inc | -0.58 | -0.55% |
| PCRXPacira Pharmaceutica... | -1.08 | -1.26% |
| THORThoratec Corp | -0.15 | -0.47% |
Data as of 10:32am ET, 07/28/2014
Financials
| Next reporting date | August 1, 2014 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $307.1M |
| Net profit margin | 20.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Michael J. Farrell |
President & Chief Operating Officer Robert Andrew Douglas |
Corporate headquarters San Diego, California |
Forecasts
.
